Results 31 to 40 of about 22,449 (147)

Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons [PDF]

open access: yes, 1987
The behavioral effects of naltrexone and quaternary naltrexone were evaluated in two groups of pigeons. One group responded under a fixed-ratio schedule of food reinforcement and was trained to discriminate between 3.2 mg/kg morphine (i.m.) and saline ...
Adams, Jill U.   +2 more
core   +1 more source

Naltrexone in the treatment of pruritus [PDF]

open access: yes, 2006
Naltrexone is a cyclopropyl derivative of oxymorphone which behaves as a competitive antagonist of opioid receptors. Naltrexone is usually used in weaning opioid-dependent patients.
S. Veraldi, F. Celotti, R. Caputo
core   +2 more sources

Opioid overdose deaths can occur in patients with naltrexone implants [PDF]

open access: yes, 2007
From Australian coronial records, we identified five deaths involving implantable naltrexone between 2000 and 2004. One man died from acute narcotism with a naltrexone implant in place and a blood naltrexone level of 0.3mg/L.
Degenhardt, Louisa   +5 more
core   +1 more source

Naltrexone maintenance treatment [PDF]

open access: yes, 2009
Naltrexone was first registered in the US in 19841 and today is available in many countries as a treatment for both heroin and alcohol dependence. This chapter reviews the safety, efficacy, and effectiveness of naltrexone as a maintenance treatment for ...
Ritter, Alison, Gibson, Amy (R17420)
core  

Compressed opiate withdrawal syndrome and naltrexone [PDF]

open access: yes, 1995
The oral opiate antagonist naltrexone is in regular use in clinical practice with abstinent opiate-dependent individuals. Acute opioid withdrawal is a well-recognised consequence of consuming naltrexone while opiate dependent.
Farrell, M, Strang, J
core   +1 more source

Stress-evoked opioid release inhibits pain in major depressive disorder [PDF]

open access: yes, 2008
To determine whether stress-evoked release of endogenous opioids might account for hypoalgesia in major depressive disorder (MDD), the μ-opioid antagonist naltrexone (50 mg) or placebo was administered double-blind to 24 participants with MDD and to 31 ...
Frew, A.K., Drummond, P.D.
core   +1 more source

Il naltrexone nel trattamento del prurito [PDF]

open access: yes, 2006
Naltrexone is a cyclopropyl derivative of oxymorphone which behaves as a competitive antagonist of opioid receptors. Naltrexone is usually used in weaning opioid-dependent patients.
S. Veraldi, R. Caputo, F. Celotti
core  

Naltrexone ameliorates functional network abnormalities in alcohol dependent individuals [PDF]

open access: yes, 2017
Naltrexone, an opioid receptor antagonist, is commonly used as a relapse prevention medication in alcohol and opiate addiction but its efficacy and the mechanisms underpinning its clinical usefulness are not well characterised.
Suckling, John   +85 more
core   +4 more sources

Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study [PDF]

open access: yes
Young Sang Lyu,1 Hongyup Ahn,2 Sangmo Hong,3 Cheol-Young Park4 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun University Hospital, Gwangju, Republic of Korea; 2Department of Statistics, Dongguk University, Seoul ...
Ahn H, Park CY, Lyu YS, Hong S
core   +1 more source

Naltrexone Induced Serotonin Syndrome [PDF]

open access: yes, 2013
Background: Serotonin syndrome resulted from hyperactivity of serotonin in nervous system and is potentially life threatening. Tramadol is known as one it's causing factors.
Behnoush, B, Memarian, A, Teimoory, M
core   +1 more source

Home - About - Disclaimer - Privacy